[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Herpes Labialis (Oral Herpes) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: HE85E35DC2DBEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Herpes Labialis (Oral Herpes) Drug pipeline report- 2020 is an annual R&D review of Herpes Labialis (Oral Herpes) pipeline candidates. The report presents the current status of all major Herpes Labialis (Oral Herpes) therapeutic compounds. Detailed insights into Herpes Labialis (Oral Herpes) pipeline development, current status, companies, drug profiles and Herpes Labialis (Oral Herpes) preclinical and clinical trials are included.

2020 Herpes Labialis (Oral Herpes) Pipeline Market Insights
Herpes Labialis (Oral Herpes) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Herpes Labialis (Oral Herpes) therapies, pipeline by phase and others are included.

Herpes Labialis (Oral Herpes) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Herpes Labialis (Oral Herpes) Therapeutic Drug candidates
Both active and inactive Herpes Labialis (Oral Herpes) pipeline drug candidates are included in the report

Herpes Labialis (Oral Herpes) Clinical Trials and preclinical Studies
Herpes Labialis (Oral Herpes) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Herpes Labialis (Oral Herpes) pipeline market developments
Herpes Labialis (Oral Herpes) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Herpes Labialis (Oral Herpes) pipeline companies in active development
The report analyzes Herpes Labialis (Oral Herpes) pipeline of the below companies-

AiCuris GmbH & Co KG, Beech Tree Labs Inc, Brandenburg Antiinfektiva GmbH, Dobecure SL, NanoViricides Inc, Provention Bio Inc, S.I.S Shulov Innovative Science Ltd, Squarex LLC, Vironova Medical AB

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
9 Companies investing in Herpes Labialis (Oral Herpes) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Herpes Labialis (Oral Herpes) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. HERPES LABIALIS (ORAL HERPES) PIPELINE MARKET INSIGHTS, 2020

1.1 Herpes Labialis (Oral Herpes) Disease Overview
1.2 Herpes Labialis (Oral Herpes) Drug Pipeline Snapshot, 2020
  1.2.1 Herpes Labialis (Oral Herpes) Pipeline Drugs by Phase
  1.2.2 Herpes Labialis (Oral Herpes) Pipeline Drugs by Company
  1.2.3 Herpes Labialis (Oral Herpes) Pipeline Drugs by Mechanism of Action
  1.2.4 Herpes Labialis (Oral Herpes) Pipeline Drugs by Route of Administration

2. HERPES LABIALIS (ORAL HERPES) COMPANY WISE PIPELINE DETAILS

AiCuris GmbH & Co KG Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Beech Tree Labs Inc Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Brandenburg Antiinfektiva GmbH Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Dobecure SL Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Provention Bio Inc Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
S.I.S Shulov Innovative Science Ltd Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Squarex LLC Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vironova Medical AB Herpes Labialis (Oral Herpes) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. HERPES LABIALIS (ORAL HERPES) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. HERPES LABIALIS (ORAL HERPES) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications